3rd Quarter - Report

W STRATEGIES, LLC for ASTRAZENECA PHARMACEUTICALS LP

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

H.R.107: to sunset the limit on maximum rebate amount for single source drugs. H.R.3: Lower Drug Costs Now Act of 2019. Regulatory and legislative proposals in the Administrations Blueprint. H.R.2113: Prescription Drug STAR Act / H.R.2296: FAIR Drug Pricing Act. FY 2020 Continuing Resolution.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: HOUSE OF REPRESENTATIVES

Bills named: H.R. 2113 (116th), H.R. 2296 (116th), H.R. 3 (116th), H.R. 107 (116th)

Health Issues HCR

Education about innovative contracting and value based payments.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.